Vanguard S&P 500 ETF vs GeneDx Holdings Corp — how do they compare? Vanguard S&P 500 ETF trades at $687.51, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| VOO | WGS | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $698.29 | $167.51 |
52-Week Low | $571.45 | $34.51 |
Market Cap | — | $1.80B |
Enterprise Value | — | $1.80B |
Trailing returns across standard periods
Latest headlines on both assets
VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →